Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01613 | 34680463 | Biomedicines | Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. | 2021 | Details |
| A01614 | 34679681 | Antioxidants (Basel) | Ameliorative Effect of Annona muricata (Graviola) Extract on Hyperglycemia Induced Hepatic Damage in Type 2 Diabetic Mice. | 2021 | Details |
| A01615 | 34679664 | Antioxidants (Basel) | Dimeric Histidine as a Novel Free Radical Scavenger Alleviates Non-Alcoholic Liver Injury. | 2021 | Details |
| A01616 | 34679651 | Antioxidants (Basel) | Association of Urinary and Dietary Selenium and of Serum Selenium Species with Serum Alanine Aminotransferase in a Healthy Italian Population. | 2021 | Details |
| A01617 | 34679515 | Diagnostics (Basel) | The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography. | 2021 | Details |
| A01618 | 34679242 | Liver Int | Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use. | 2021 | Details |
| A01619 | 34679051 | Vet Sci | Changes in Serum Lipid Profiles among Canine Patients Suffering from Chronic Hepatitis. | 2021 | Details |
| A01620 | 34678858 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. | 2022 | Details |
| A01622 | 34678374 | Toxicol Appl Pharmacol | Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3. | 2021 | Details |
| A01623 | 34678296 | Clin Chim Acta | The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. | 2021 | Details |
| A01624 | 34677420 | Metabolites | Molecular Mechanisms of the SLC13A5 Gene Transcription. | 2021 | Details |
| A01625 | 34677409 | Metabolites | Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review. | 2021 | Details |
| A01626 | 34677372 | Metabolites | In Utero Exposure to Persistent Organic Pollutants and Childhood Lipid Levels. | 2021 | Details |
| A01627 | 34677008 | Hepatol Commun | Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01628 | 34676692 | Hepatol Commun | Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus. | 2021 | Details |
| A01629 | 34676233 | Front Nutr | NAFLD and Physical Exercise: Ready, Steady, Go! | 2021 | Details |
| A01630 | 34675940 | Front Immunol | Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases. | 2021 | Details |
| A01631 | 34675931 | Front Immunol | Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice. | 2021 | Details |
| A01634 | 34675338 | Sci Rep | Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis. | 2021 | Details |
| A01635 | 34675003 | Diabetes | Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice. | 2021 | Details |
| A01636 | 34674650 | BMC Gastroenterol | Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study. | 2021 | Details |
| A01637 | 34674510 | Endocrinol Metab (Seoul) | Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study. | 2021 | Details |
| A01638 | 34674097 | Inflammation | Deoxycholic Acid Promotes Pyroptosis in Free Fatty Acid-Induced Steatotic Hepatocytes by Inhibiting PINK1-Mediated Mitophagy. | 2021 | Details |
| A01639 | 34671996 | Aliment Pharmacol Ther | Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis. | 2021 | Details |
| A01640 | 34671210 | Int J Biol Sci | Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling. | 2021 | Details |
| A01641 | 34671102 | Nat Rev Endocrinol | Metabolic implications of pancreatic fat accumulation. | 2021 | Details |
| A01642 | 34670068 | Ann Pediatr Endocrinol Metab | Wilson disease diagnosed incidentally by targeted gene panel sequencing in a Korean boy with severe obesity. | 2021 | Details |
| A01644 | 34670043 | N Engl J Med | Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01645 | 34670042 | N Engl J Med | A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. | 2021 | Details |
| A01646 | 34669440 | Sci Transl Med | Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors. | 2021 | Details |
| A01647 | 34669319 | Minerva Endocrinol (Torino) | Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A01648 | 34669068 | J Med Ultrason (2001) | MRI-derived proton density fat fraction. | 2021 | Details |
| A01649 | 34668765 | J Med Food | Ameliorative Effect of Myricetin on Nonalcoholic Fatty Liver Disease in ob/ob Mice. | 2021 | Details |
| A01650 | 34668658 | Hepatol Commun | Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01651 | 34668597 | Hepatology | High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. | 2021 | Details |
| A01652 | 34667947 | JHEP Rep | New targets for NAFLD. | 2021 | Details |
| A01653 | 34666156 | Clin Gastroenterol Hepatol | The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States. | 2021 | Details |
| A01654 | 34666041 | J Biol Chem | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2021 | Details |
| A01655 | 34666025 | Clin Chim Acta | Gut microbiome and metabolic response in non-alcoholic fatty liver disease. | 2021 | Details |
| A01656 | 34665792 | Clin Transl Gastroenterol | Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A01657 | 34665236 | J Mol Cell Biol | cGAS‒STING signaling and function in metabolism and kidney diseases. | 2021 | Details |
| A01658 | 34664321 | J Clin Lab Anal | Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case-control study. | 2021 | Details |
| A01659 | 34664301 | J Gastroenterol Hepatol | Diet and gut microbiome in fatty liver and its associated liver cancer. | 2021 | Details |
| A01660 | 34664288 | J Food Biochem | Sesamol ameliorates hepatic lipid accumulation and oxidative stress in steatosis HepG2 cells via the PPAR signaling pathway. | 2021 | Details |
| A01661 | 34663793 | Nutr Diabetes | Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. | 2021 | Details |
| A01662 | 34663576 | Diabetes | Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity. | -- | Details |
| A01663 | 34663438 | Diabetol Metab Syndr | The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial. | 2021 | Details |
| A01664 | 34662928 | Pediatr Obes | Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. | 2021 | Details |
| A01665 | 34662732 | Environ Toxicol Pharmacol | Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases. | 2021 | Details |
| A01666 | 34662449 | Hepatology | Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. | 2022 | Details |
| A01667 | 34661762 | J Genet Eng Biotechnol | NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients. | 2021 | Details |
| A01668 | 34660809 | J Diabetes Res | Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01669 | 34660604 | Front Cell Dev Biol | Dual Regulation of Tank Binding Kinase 1 by BRG1 in Hepatocytes Contributes to Reactive Oxygen Species Production. | 2021 | Details |
| A01670 | 34660454 | J Family Med Prim Care | Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data. | 2021 | Details |
| A01671 | 34660070 | Cureus | A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population. | 2021 | Details |
| A01672 | 34659501 | Exp Ther Med | Non-alcoholic fatty liver disease and hematologic manifestations (Review). | 2021 | Details |
| A01673 | 34659439 | Evid Based Complement Alternat Med | Ginsenoside Re Improves Inflammation and Fibrosis in Hepatic Tissue by Upregulating PPARγ Expression and Inhibiting Oxidative Stress in db/db Mice. | 2021 | Details |
| A01674 | 34659388 | Bioinorg Chem Appl | The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. | 2021 | Details |
| A01675 | 34659125 | Front Endocrinol (Lausanne) | Predictive Modeling of MAFLD Based on Hsp90α and the Therapeutic Application of Teprenone in a Diet-Induced Mouse Model. | 2021 | Details |
| A01676 | 34658353 | Nan Fang Yi Ke Da Xue Xue Bao | [Quantitative analysis of differential proteins in liver tissues of patients with non-alcoholic steatohepatitis using iTRAQ technology]. | 2021 | Details |
| A01677 | 34658280 | Hisp Health Care Int | Perceived Barriers to Weight Loss among Hispanic Patients with Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01678 | 34657611 | Lipids Health Dis | Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. | 2021 | Details |
| A01679 | 34657040 | Cytogenet Genome Res | PinX1 Depletion Improves Liver Injury in a Mouse Model of Nonalcoholic Fatty Liver Disease via Increasing Telomerase Activity and Inhibiting Apoptosis. | 2021 | Details |
| A01680 | 34656650 | J Hepatol | Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling. | 2021 | Details |
| A01681 | 34656648 | Metabolism | CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice. | 2021 | Details |
| A01682 | 34655812 | Cell Mol Gastroenterol Hepatol | Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation. | 2021 | Details |
| A01683 | 34655465 | J Gastroenterol Hepatol | Altered bile acid glycine : taurine ratio in the progression of chronic liver disease. | 2021 | Details |
| A01684 | 34654976 | Curr Gastroenterol Rep | Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide. | 2021 | Details |
| A01685 | 34654875 | Acta Pharmacol Sin | Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway. | 2021 | Details |
| A01687 | 34653759 | Biomed Pharmacother | Effects of DHA dietary intervention on hepatic lipid metabolism in apolipoprotein E-deficient and C57BL/6J wild-type mice. | 2021 | Details |
| A01688 | 34653686 | Ann Hepatol | Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016. | 2021 | Details |
| A01689 | 34653601 | J Nutr Biochem | Copper (Cu) induced changes of lipid metabolism through oxidative stress-mediated autophagy and Nrf2/PPARγ pathways. | 2021 | Details |
| A01690 | 34653272 | Aliment Pharmacol Ther | Trends in statin utilisation in US adults with non-alcoholic fatty liver disease. | 2021 | Details |
| A01691 | 34653177 | PLoS One | Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis. | 2021 | Details |
| A01692 | 34652813 | FEBS Lett | Activation of the purinergic receptor P2X7 improves hepatosteatosis by promoting lipophagy. | 2021 | Details |
| A01693 | 34652536 | Mol Cell Biochem | Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3. | 2021 | Details |
| A01694 | 34652089 | J Sports Med Phys Fitness | Changes in mitochondrial biogenesis and fatty liver indicators in rat following continuous and high intensity interval training. | 2021 | Details |
| A01695 | 34652078 | J Breast Cancer | Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival. | 2021 | Details |
| A01696 | 34651580 | J Clin Invest | Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. | 2021 | Details |
| A01697 | 34651578 | J Clin Invest | Targeting adipose tissue to tackle NASH: SPARCL1 as an emerging player. | 2021 | Details |
| A01698 | 34651285 | J Physiol Biochem | Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. | 2021 | Details |
| A01699 | 34651015 | Front Mol Biosci | RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases. | 2021 | Details |
| A01700 | 34650994 | Front Med (Lausanne) | Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. | 2021 | Details |
| A01702 | 34650394 | Food Nutr Res | Chronic liquid fructose supplementation does not cause liver tumorigenesis but elicits clear sex differences in the metabolic response in Sprague-Dawley rats. | 2021 | Details |
| A01703 | 34649958 | Cancer Epidemiol Biomarkers Prev | Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01704 | 34649337 | Biomed Pharmacother | Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology. | 2021 | Details |
| A01705 | 34649307 | Clin Mol Hepatol | Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods. | 2021 | Details |
| A01706 | 34649219 | Biomed Pharmacother | Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment. | 2021 | Details |
| A01707 | 34648896 | J Hepatol | Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis. | 2021 | Details |
| A01708 | 34648769 | Metabolism | Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. | 2021 | Details |
| A01709 | 34647407 | Chembiochem | Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1. | 2021 | Details |
| A01710 | 34646997 | EClinicalMedicine | acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study. | 2021 | Details |
| A01711 | 34646672 | Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01712 | 34646529 | Food Sci Nutr | Sargassum fusiforme polysaccharide attenuates high-sugar-induced lipid accumulation in HepG2 cells and Drosophila melanogaster larvae. | 2021 | Details |
| A01713 | 34646360 | Therap Adv Gastroenterol | Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. | 2021 | Details |
| A01714 | 34646233 | Front Endocrinol (Lausanne) | Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders. | 2021 | Details |
| A01715 | 34646017 | Nature | Convergent somatic mutations in metabolism genes in chronic liver disease. | 2021 | Details |
| A01716 | 34642957 | J Food Sci | Heukcha, naturally post-fermented green tea extract, ameliorates diet-induced hypercholesterolemia and NAFLD in hamster. | 2021 | Details |
| A01717 | 34642390 | Sci Rep | Development and validation of a neural network for NAFLD diagnosis. | 2021 | Details |
| A01718 | 34641807 | BMC Geriatr | A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80. | 2021 | Details |